Abstract
Mechanical forces are important in the regulation of physiological homeostasis and the development of disease. The application of mechanical forces to cultured cells is often performed using specialized systems that lack the flexibility and throughput of other biological techniques. In this study, we developed a high throughput platform for applying complex dynamic mechanical forces to cultured cells. We validated the system for its ability to accurately apply parallel mechanical stretch in a 96 well plate format in 576 well simultaneously. Using this system, we screened for optimized conditions to stimulate increases in Oct-4 and other transcription factor expression in mouse fibroblasts. Using high throughput mechanobiological screening assays, we identified small molecules that can synergistically enhance the increase in reprograming-related gene expression in mouse fibroblasts when combined with mechanical loading. Taken together, our findings demonstrate a new powerful tool for investigating the mechanobiological mechanisms of disease and performing drug screening in the presence of applied mechanical load.
Subject terms: Biological techniques, Biophysics, Drug discovery, Stem cells
Introduction
Cellular reprograming is a process in which differentiated, mature cells are converted into induced pluripotent stem cells (iPSCs) through the expression of specific transcription factors. Generation of iPSCs is typically achieved through the expression of octamer-binding transcription factor-4 (Oct-4), Kruppel-like factor 4 (Klf-4), Sex Determining Region Y Box 2 (Sox2), and v-Myc Myelocytomatosis Viral Oncogene Homolog (c-Myc)1. The discovery of the means to reprogram mature cells to iPSCs and subsequently differentiate them into defined lineages has immense potential to revolutionize cell-based therapeutics, drug screening and scientific investigation of many diseases. However, current protocols for creating iPSCs are often inefficient and time-consuming2,3. Moreover, genetic modification of cells to overexpress the transcription factors has the risk of creating mutations in the reprogrammed cells and tumorigenicity is a major concern with iPSC-based therapies4. Several groups have found that small molecules can replace some or all of the transcription factors that induce cellular reprograming5–8, supporting that reprogramming is possible in the absence of exogenous gene delivery.
Biophysical forces are receiving increased recognition as important modulators of biological processes in many fields including cancer9,10, stem cell biology11–14 and embryological development15. Recent work has suggested a link between the mechanical environment and pluripotency16. In addition, mechanical force can lead to chromatin remodeling and altered binding of transcription factors17,18. Recent studies have also shown that application of mechanical strain can reduce the expression of pluripotency in mouse embryonic stem cells19,20. In human pluripotent stem cells (hPSCs), mechanical strain helped to maintain pluripotency through increased expression Nodal, transforming growth factor-β (TGF-β), and Activin21,22. However, in other studies, mechanical strain reduced the expression of pluripotency transcription factors and signaling pathways related to pluripotency in iPSCs23. Mechanical stretch also enhanced the reprograming of cells treated with retrovirus-delivered pluripotency transcription factors without altering the efficiency of viral transduction24. Other studies have linked alterations in pluripotency to changes in cell shape or substrate stiffness25–27. Thus, while the mechanical environment has a powerful effect on cellular reprogramming it is unclear how best to optimize applied forces and/or mechanical environment to enhance pluripotency.
In this study we have developed a flexible, high throughput system for the studying cellular mechanobiology. Systems for studying applied mechanical forces to cultured cells often use flexible cell culture surfaces that can be expanded through applied mechanical forces28–30, expansion of the membrane can be induced through the displacement of a piston31,32, pneumatic suction33 or direct traction on the membrane34. These systems have been reviewed extensively in several past and recent reviews28,29,35. Systems using a rotational motor with a cam to drive piston motion are limited in that they can apply only one waveform without modifying the cam shape31. Pneumatic systems are commercially available but also have limitations in the dynamics of the pneumatic system and ability to apply only a single strain at one time36. The throughput for these systems is often a major limitation, which prevents the performance of screening studies for pathway and drug discovery. While there have been studies to expand the throughput of mechanical loading system for cells, these systems often make compromises in the uniformity of the strains applied, dynamics of strain application and robustness in order to achieve increased throughput37,38. Here, we developed a high throughput system that allows the application of mechanical stretch to cells in a high throughput format of up to 576 wells simultaneously. The system is configured with removable multi-well plates that can be used in high content imaging systems and plate reading assays. In addition, the system allows the application of arbitrary waveforms with highly controlled dynamics, allowing the simulation of complex physiological forces.
Using this mechanobiological screening platform, we examined whether there were mechanical conditions that could induce somatic cell (fibroblasts) to express reprogramming factors that are involved in the development of pluripotency. We found that high level of mechanical strain and physiological loading induced the expression of reprograming factors in mouse embryonic fibroblasts (MEFs). By combining mechanical conditioning with a drug screen of small molecule signaling modulators, we also identified compounds that could further enhance the expression of Oct-4 in mouse fibroblasts. Our studies reveal that optimized mechanical stimulation combined with small molecule inhibitors can markedly enhance the expression of reprogramming factors in fibroblasts in the absence of transgene delivery.
Results
High throughput system for studying stem cell mechanobiology
We created a high throughput mechanical loading system that allows the application of mechanical stretch to cells cultured in six 96-well plates simultaneously. The system applies mechanical load by displacing an array of pistons mounted on a platen through a flexible bottom culture plate. The high throughput biaxial oscillatory strain system (HT-BOSS) drives the motion of a platen using a tubular linear motor (Fig. 1A). Teflon pistons are mounted on the platen that can be driven to displace a flexible culture surface within a custom culture plate (Fig. 1B). This system can apply strains based on the displacement of the piston and there is a linear relation of displacement to strain for a broad range of mechanical strains (Fig. 2A,B). The height of each piston can be adjusted individually, allowing calibration of each piston for accurate strain application. We calibrated the strain applied to each of the 576 wells in the system and found a high degree of accuracy and repeatability for the strain application across all of the wells (Fig. 2C). The system uses a true linear (voice coil) motor that allows customizable displacements to create complex dynamic strain waveforms. We verified that the system could apply the sine waveform and two physiologic strain waveforms derived from the displacement of the arterial wall in the aorta and brachial arteries (Fig. 2D)39. As the motion of fluid within the cultured wells due to piston motion could create shear stress, we created a computational fluid flow model for the inside of the well during the application of mechanical strain to gauge the significance of this potential effect. From the simulations, we found that the average shear stress on the culture surface scaled in an approximately linear manner with the frequency of loading and maximum strain (Fig. 3). The shear stress applied was very low in magnitude and in the range of ~ 0.5 to 4 mPa over all of the conditions tested. In comparison to simulations of a larger format system with 35 mm diameter wells, the shear stress generated in this high throughput system was about tenfold lower (compared to 6.35 mm diameter wells)39,40. In the high throughput format, the system can apply a maximal of 17.5% strain in all of the wells.
Multi-strain screening reveals that high level of mechanical strain leads to increased expression of Oct-4, Sox2 and SSEA1
To test the ability of the system to perform mechanobiological screens, we examined the hypothesis that the expression of reprogramming factors may be regulated through the application of mechanical forces. Octamer-binding transcription factor 4 (Oct-4) is a transcription factor that is key in the maintenance and reinitiation of pluripotency41. We applied mechanical strain to mouse embryonic fibroblasts (MEFs) that expressed an Oct-4 enhanced green fluorescent protein (eGFP) transgene at 0.1 Hz with varying maximal strain from 0 to 17.5% strain. Using the high throughput loading system, we applied a range of load simultaneously by adjusting the heights of the pistons and calibrating the maximum strain applied (Fig. 4A,B). Using a plate reader, we assayed the expression of Oct-4 over seven days of loading (four hours of loading per day). We found that most levels of mechanical strain increased Oct-4 expression from approximately 1.5 to 2.5 fold and that the highest levels of Oct-4 were observed in cells exposed to 17.5% strain (Fig. 4C,D). Sox2 is a key transcription factor in the maintenance and development of pluripotency42,43. Stage specific embryonic antigen 1 (SSEA1) is an early marker of the development of pluripotency during the development of induced pluripotent stem cells from mouse embryonic fibroblasts (MEFs)44. We performed loading of MEFs under similar conditions and then immunostained for pluripotency factors Sox2 and SSEA1. We found significant increases in Sox2 at maximal strains greater than 5%, with a maximal increase at 17.5% strain (Fig. 5A,B). In addition, we found significant increases in SSEA1 with all levels of strain and a maximal increase with 17.5% strain (Fig. 5A,C).
High throughput mechanobiological screen of small molecule inhibitors combined with mechanical load to enhance Oct-4 expression in MEFs
A key capability of the HT-BOSS system is the ability to perform drug screening in the presence of applied mechanical forces. This enables the investigation of synergy between mechanical forces and pharmacological agents. After observing the increases in reprogramming factors in MEFs, we then screen a small drug library to search for compound that may synergistically enhance reprogramming factor expression in MEFs. We performed a mechanobiological screen in which we applied 17.5% strain to Oct-4 eGFP MEFs at 0.1 Hz for 14 days. We applied the mechanical load using either a sinusoidal waveform or a brachial waveform that has a shape that mimics the strain in the brachial artery during the cardiac cycle. In addition, we treated the cells with a library of small molecule kinase inhibitors. Under pharmacological treatment in static conditions, many of the kinase inhibitors decreased Oct-4 expression below baseline levels in the MEFs (Fig. 6). In particular, inhibitors to the rho-associated protein kinase (ROCK), Ras homolog family member A (RhoA), Janus kinase (JAK) family receptors, signal transducer and activator of transcription-3 (Stat-3), c-kit and macrophage-stimulating protein-1/2 (MST1/2) inhibited the load-induced increase in Oct-4 expression. Cells treated with sine waveform and kinase inhibitors had predominantly either no alteration in Oct-4 or a reduction in Oct-4 expression (Fig. 6A–C). Under brachial waveform loading, there was increase in Oct-4 expression with most treatments (Fig. 6D). Notably, treatment with DMSO increased the Oct-4 expression in combination with brachial waveform mechanical loading in comparison to control cells with brachial loading. In addition, several of the kinase inhibitors increased the Oct-4 expression including a protein kinase Cβ (PKCβ) inhibitor (Enzastaurin; CAS 170364-57-5), a β-Catenin/Transcription Factor (Tcf) Inhibitor (FH535; CAS 108409-83-2), and a Glycogen Synthase Kinase-3 Kinase (GSK-3K) inhibitor (SB-431542; CAS 280744-09-4), in combination with brachial loading. To further investigate the expression of pluripotency related markers in the MEFs, we treated MEFs with a subset of conditions from our high throughput screen that increased Oct-4 GFP expression. NANOG is transcription factor that is important in maintaining pluripotency and reaching a pluripotent ground state for cells45. We then examined expression of Sox2 and NANOG by immunostaining. We found significant increases in Sox2 and NANOG with the brachial waveform and treatment with some of kinase inhibitors (Fig. 7). However, the inhibitors did not have synergistic increases in expression of Sox2 and NANOG in combination with brachial loading as seen with Oct-4.
Discussion
While iPSCs have immense potential for their ability to mimic disease in vitro, there remain concerns for the use of genetically modified cells as therapeutics in patients. Thus, reprogramming strategies that do not use genetic modification would be highly advantageous for enhancing the therapeutic potential of iPSCs. Several studies have found that small molecule inhibitors can substitute for one or more pluripotency transcription factors5–8. However, prior studies have found that mechanical forces can both inhibit and enhance the development of pluripotency. In this study, we developed a novel mechanical screening system that enabled a more complete exploration of mechanical conditions that could potentially alter the development of pluripotency in somatic cells. Using this screening system, we found optimal mechanical conditions that enhanced the expression of pluripotency transcriptions factors in fibroblasts and that this could be further enhanced for Oct-4 through treatment with small molecule inhibitors.
In our study, high levels of mechanical strain were most effective in inducing pluripotency transcription factor expression. In addition, the use of a physiologic waveform (brachial) with a high strain rate was optimal for inducing Oct-4 expression in fibroblasts. The expression of Oct-4 in MEFs was further increased by adding in inhibitors to PKCβ, β-catenin/Tcf, or TGF-βRI/ALK4/ALK7 in combination with the optimal mechanical loading conditions. Mechanical strain alone was able to increase Oct-4 eGFP expression by nearly 2.5 fold. This effect was present after one day of loading and increased slightly over time for the seven days. With the addition of specific inhibitors with mechanical load, the enhancement of Oct-4 eGFP was increased to 3.2 fold over baseline levels. In other reprogramming factors, brachial loading did increase the expression of Sox2 and NANOG. However, the inhibitors identified from the Oct-4 screen did not further increase the effect with brachial waveform loading on these reprogramming factor and in some cases blocked the increase caused by the mechanical loading. These findings suggest that the small molecules identified in the screen are specific to Oct-4 in their ability to enhance the load-induced effects on reprograming factor expression.
One potential limitation of our studies is the use of immunofluorescent assays for the assessment of the pluripotent markers. While this technique has limitations, it interfaces well with standard high content cell screening methods and allows the quantification of cell response on the single cell level, allowing an assessment of cell-to-cell variability, subpopulation response and heterogeneity (common issues in studies using stem cells). Genetic reporter constructs such as the Oct-4 reporter used in this study can overcome some of these limitations but also have caveats for use in human cells where viral transduction and selection with antibiotics are required for establishing stable cell lines. In this study, we used cells derived from a transgenic mouse, which did not require viral transduction.
Overall, our results demonstrate the ability of combined mechanical/pharmacological conditioning to prime the pluripotency of somatic cells in the absence of genetic modification. The induction of the transcription factors was highly dependent on the magnitude of mechanical strain and the complex dynamics of the applied waveform. Moreover, the response of the cells to drugs was highly dependent on the mechanical conditions, with compounds causing opposing response in static versus loaded conditions. Thus, mechanobiological screening may provide complementary enhancement of strategies for chemically inducing pluripotency and aid in the development of safe methods for creating iPSCs for therapy in human patients.
Materials and methods
Cell culture
Mouse embryonic fibroblasts (PrimCells LLC) or Oct-4 eGFP reporter expressing MEFs (EMD Millipore) at passages 5 were cultured in 4.5 g/L d-glucose DMEM medium supplemented with 10% fetal bovine serum, l-glutamine, and penicillin/streptomycin. The MEFs were obtained from CF1 mice and were derived from 13-day-old embryos (pooled cells from male and female mice). All cells were cultured at 37 °C and 5% CO2. For passaging, 70% confluent MEFs were first washed with PBS. The cells were agitated with 0.25% EDTA-trypsin at 37 °C for 1 min. Cell suspension was then collected and centrifuged at 500g for 5 min. The cells were then seeded to a new substrate at 2,000 cells per cm2.
Mechanical loading device
Strain was applied to cells using a custom made device that displaces pistons through the flexible culture surface. The device operates using a true linear motor that drives a platen on motion rails. Linear ball bearings are used along the rails to minimize friction, while fixed springs on the rods help reduce the load on the motor and prevent the platen from moving while the device is turned off. There are 576 individual polytetrafluoroethylene (PTFE) pistons mounted on the platen that are removable and can be calibrated individually through thin shims. A top plate on the system has mounting holes for custom designed culture plates that hold a silicone membrane sandwiched between steel plates and silicone gaskets. The silicone membrane can be coated to allow culture of cells and the entire geometry matches that of a standard 96 well culture plate. Mechanical strain is applied when the pistons are moved into the silicone membrane, causing displacement and application of stretch to the cells. The linear motor is hygienically sealed and feedback controlled by software that regulates the current through the coils around the motor (Copley Motion). The motor has a resolution of displacement of 10 μm. To avoid excess heat from the current generated and from high temperature inside cell incubators, a cooling system is integrated with an external water bath circulating chilled water into the motor’s enclosure.
Flexible-bottom culture plate assembly
The cell culture plate was assembled by sandwiching custom made parts with the flexible silicone rubber to provide a cell culture substrate. The culture plate consists of a polycarbonate top plate and aluminum bottom plate that are held together by eight screws. Sandwiched between the top and bottom plate is a 0.005′′ thick silicone sheet (Specialty Manufacturing, Inc.) with a rubber gasket to prevent leaking. The plates are sterilized prior to cell seeding by UV light and are coated by treatment with 50 µg/mL fibronectin at 37 °C overnight. On the day of mechanical loading, the plates were mounted to the top plate of the device with eight additional screws.
Calibration of mechanical strain
Mechanical strain applied to the flexible membrane was measured by recording changes in the marks drawn on the membrane. A uniform array of marks was created on the cell culture surface using silicone glue. The pistons were displaced at small increments through the membrane and a high magnification image of the mark was recorded using a high-resolution camera (Basler AG). The displacement of the membrane was measured using Metamorph Imaging software (version 7.8; Molecular Devices, Sunnyvale, CA). For dynamic mechanical loading, strain was measured by recording a video at 60 frames per second. The membrane was displaced in sinusoidal, aortic, and brachial waveforms created from clinical arterial distension data39. For each waveform, three cycles of the waveform were recorded and averaged.
Computational modeling of the system
Fluid mechanics in the cell culture media was modelled using finite element software (COMSOL). Briefly, a cylindrical shape fluid structure was used to model a single well with viscosity and density of standard Dulbecco's modified Eagle's medium (DMEM) media. The bottom surface was displaced in a sinusoidal motion over time with three frequencies (0.1 Hz, 1 Hz, and 2 Hz) in combination with three maximum magnitudes (1%, 5%, and 10%). A series of mesh and tolerance optimization were performed to optimize these parameters. The maximum and average fluid velocities at various cross sections were computed. Average shear stress in various locations and over various time points were computed as well with the focus on the location of the bottom surface undergoing displacement where the cells are located.
Immunostaining
Following the treatments, the cells were fixed in 4% paraformaldehyde in PBS for 10 min followed by washing and permeabilization with 0.1% Triton X-100 PBS for 5 min. Next, samples were blocked with PBS containing 5% fetal bovine serum (FBS) and 1% bovine serum albumin (BSA) for 40 min. After washing, cells were incubated with primary antibodies at 1:100 dilution ratio in PBS with 1% BSA overnight at 4 °C. Primary antibodies used include NANOG (ab80892; Abcam), Sox2 (4744S; Cell Signaling Technology), and SSEA-1 (ab79351; Abcam). The samples were then washed twice in phosphate buffered saline (PBS) with 1% BSA and incubated with secondary antibodies at 1:1,000 dilution ratio in PBS with 1% BSA for 2 h in a light protected environment. Cells were then washed with PBS with 1% BSA prior to mounting in anti-fade media (Vector Laboratories, Inc.). The samples were imaged using FV10i Confocal Laser Scanning Microscope (Olympus, Inc.). Images of the fluorescent cell cultures were then traced in Adobe Photoshop for fluorescence intensity quantification.
Multi-strain mechanical loading and measurement of Oct-4 GFP expression
To determine the optimal strain for Oct-4 expression in MEF, Oct-4 eGFP reporter expressing MEFs were exposed to either static or sinusoidal waveform loading for 8 h a day for 7 days using the multi-strain configuration of HT-BOSS, where the cells were exposed to maximal strain ranging from 0.0 to 17.5%, in 2.5% intervals. For measuring the expression of Oct-4 eGFP, plate reader was used (Varioskan; Thermo Fisher). Briefly, culture media was replaced with Tyrode’s Solution every day prior to the fluorescence measurement. After plate reading, the Tyrode’s solution was replaced with cell culture media.
Kinase inhibitor drug library
For the kinase screening study, Oct-4 eGFP expressing MEFs were cultured under static, sinusoidal waveform, or brachial waveform loading for 4 h per day for 14 days at 0.1 Hz and 17.5% maximal strain. During loading, the cells were treated with media no treatment, 1 μM DMSO, or one of the 40 kinase inhibitors listed in Supplemental Table 1 at 1 μM (Cayman Chemicals). Each day, the cell culture media were replaced with Tyrode’s Solution and the Oct-4 GFP expression was measured using a plate reader. The Tyrode’s solution was replaced with media containing treatment every day prior to stretching.
Statistical analysis
All results are shown as mean ± standard error of the mean. Multiple comparisons between groups were analyzed by two-way ANOVA followed by a Tukey post-hoc or a Dunnett post-hoc test when testing multiple comparisons versus a control group. A p-value of 0.05 or less was considered statistically significant.
Supplementary information
Acknowledgements
The authors gratefully acknowledge funding through the American Heart Association (17IRG33410888), the DOD CDMRP (W81XWH-16-1-0580; W81XWH-16-1-0582) and the National Institutes of Health (1R21EB023551-01; 1R21EB024147-01A1; 1R01HL141761-01) to ABB.
Author contributions
J.L., M.A.O., P.M., Y.U., L.S. and M.W. conducted the experiments. J.L. and A.B.B. designed experiments, performed data analysis and wrote the paper.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
is available for this paper at 10.1038/s41598-020-72158-5.
References
- 1.Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024. [DOI] [PubMed] [Google Scholar]
- 2.Lujan E, et al. Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature. 2015;521:352–356. doi: 10.1038/nature14274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Polo JM, et al. A molecular roadmap of reprogramming somatic cells into iPS cells. Cell. 2012;151:1617–1632. doi: 10.1016/j.cell.2012.11.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ben-David U, Benvenisty N. The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer. 2011;11:268–277. doi: 10.1038/nrc3034. [DOI] [PubMed] [Google Scholar]
- 5.Ichida JK, et al. A small-molecule inhibitor of tgf-Beta signaling replaces sox2 in reprogramming by inducing nanog. Cell Stem Cell. 2009;5:491–503. doi: 10.1016/j.stem.2009.09.012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Lin T, et al. A chemical platform for improved induction of human iPSCs. Nat. Methods. 2009;6:805–808. doi: 10.1038/nmeth.1393. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Zhu S, et al. Reprogramming of human primary somatic cells by OCT4 and chemical compounds. Cell Stem Cell. 2010;7:651–655. doi: 10.1016/j.stem.2010.11.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Hou P, et al. Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds. Science. 2013;341:651–654. doi: 10.1126/science.1239278. [DOI] [PubMed] [Google Scholar]
- 9.Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annu. Rev. Biomed. Eng. 2014;16:321–346. doi: 10.1146/annurev-bioeng-071813-105259. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Heldin CH, Rubin K, Pietras K, Ostman A. High interstitial fluid pressure—an obstacle in cancer therapy. Nat. Rev. Cancer. 2004;4:806–813. doi: 10.1038/nrc1456. [DOI] [PubMed] [Google Scholar]
- 11.Lee DA, Knight MM, Campbell JJ, Bader DL. Stem cell mechanobiology. J. Cell Biochem. 2011;112:1–9. doi: 10.1002/jcb.22758. [DOI] [PubMed] [Google Scholar]
- 12.Yang MT, Fu J, Wang YK, Desai RA, Chen CS. Assaying stem cell mechanobiology on microfabricated elastomeric substrates with geometrically modulated rigidity. Nat. Protoc. 2011;6:187–213. doi: 10.1038/nprot.2010.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell. 2006;126:677–689. doi: 10.1016/j.cell.2006.06.044. [DOI] [PubMed] [Google Scholar]
- 14.Henderson K, Sligar AD, Le VP, Lee J, Baker AB. Biomechanical regulation of mesenchymal stem cells for cardiovascular tissue engineering. Adv. Healthc. Mater. 2017;6:2. doi: 10.1002/adhm.201700556. [DOI] [PubMed] [Google Scholar]
- 15.Goldie LC, Nix MK, Hirschi KK. Embryonic vasculogenesis and hematopoietic specification. Organogenesis. 2008;4:257–263. doi: 10.4161/org.4.4.7416. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ireland RG, Simmons CA. Human pluripotent stem cell mechanobiology: manipulating the biophysical microenvironment for regenerative medicine and tissue engineering applications. Stem Cells. 2015;33:3187–3196. doi: 10.1002/stem.2105. [DOI] [PubMed] [Google Scholar]
- 17.Iyer KV, Pulford S, Mogilner A, Shivashankar GV. Mechanical activation of cells induces chromatin remodeling preceding MKL nuclear transport. Biophys. J. 2012;103:1416–1428. doi: 10.1016/j.bpj.2012.08.041. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tajik A, et al. Transcription upregulation via force-induced direct stretching of chromatin. Nat. Mater. 2016;15:1287–1296. doi: 10.1038/nmat4729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Hazenbiller O, Duncan NA, Krawetz RJ. Reduction of pluripotent gene expression in murine embryonic stem cells exposed to mechanical loading or Cyclo RGD peptide. BMC Cell Biol. 2017;18:32. doi: 10.1186/s12860-017-0148-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Hazenbiller O, Nasr S, Krawetz RJ, Duncan NA. Effect of mechanical strain on the pluripotency of murine embryonic stem cells seeded in a collagen-I scaffold. J. Orthop. Res. 2018;36:799–807. doi: 10.1002/jor.23749. [DOI] [PubMed] [Google Scholar]
- 21.Saha S, Ji L, de Pablo JJ, Palecek SP. TGFbeta/Activin/nodal pathway in inhibition of human embryonic stem cell differentiation by mechanical strain. Biophys. J. 2008;94:4123–4133. doi: 10.1529/biophysj.107.119891. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Saha S, Ji L, de Pablo JJ, Palecek SP. Inhibition of human embryonic stem cell differentiation by mechanical strain. J. Cell Physiol. 2006;206:126–137. doi: 10.1002/jcp.20441. [DOI] [PubMed] [Google Scholar]
- 23.Teramura T, et al. Mechanical stimulation of cyclic tensile strain induces reduction of pluripotent related gene expressions via activation of Rho/ROCK and subsequent decreasing of AKT phosphorylation in human induced pluripotent stem cells. Biochem. Biophys. Res. Commun. 2012;417:836–841. doi: 10.1016/j.bbrc.2011.12.052. [DOI] [PubMed] [Google Scholar]
- 24.Kim YM, et al. Effects of mechanical stimulation on the reprogramming of somatic cells into human-induced pluripotent stem cells. Stem Cell Res. Ther. 2017;8:139. doi: 10.1186/s13287-017-0594-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Macri-Pellizzeri L, et al. Substrate stiffness and composition specifically direct differentiation of induced pluripotent stem cells. Tissue Eng. Part A. 2015;21:1633–1641. doi: 10.1089/ten.TEA.2014.0251. [DOI] [PubMed] [Google Scholar]
- 26.Eroshenko N, Ramachandran R, Yadavalli VK, Rao RR. Effect of substrate stiffness on early human embryonic stem cell differentiation. J. Biol. Eng. 2013;7:7. doi: 10.1186/1754-1611-7-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Maldonado M, et al. Lineage- and developmental stage-specific mechanomodulation of induced pluripotent stem cell differentiation. Stem Cell Res. Ther. 2017;8:216. doi: 10.1186/s13287-017-0667-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Brown TD. Techniques for mechanical stimulation of cells in vitro: a review. J. Biomech. 2000;33:3–14. doi: 10.1016/s0021-9290(99)00177-3. [DOI] [PubMed] [Google Scholar]
- 29.Davis CA, et al. Device-based in vitro techniques for mechanical stimulation of vascular cells: a review. J. Biomech. Eng. 2015;137:040801. doi: 10.1115/1.4029016. [DOI] [PubMed] [Google Scholar]
- 30.MacQueen L, Sun Y, Simmons CA. Mesenchymal stem cell mechanobiology and emerging experimental platforms. J. R. Soc. Interface. 2013;10:20130179. doi: 10.1098/rsif.2013.0179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Schaffer JL, et al. Device for the application of a dynamic biaxially uniform and isotropic strain to a flexible cell culture membrane. J. Orthop. Res. 1994;12:709–719. doi: 10.1002/jor.1100120514. [DOI] [PubMed] [Google Scholar]
- 32.Baker AB, et al. Endothelial cells provide feedback control for vascular remodeling through a mechanosensitive autocrine TGF-beta signaling pathway. Circ. Res. 2008;103:289–297. doi: 10.1161/CIRCRESAHA.108.179465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Zhong C, et al. Rho-mediated contractility exposes a cryptic site in fibronectin and induces fibronectin matrix assembly. J. Cell Biol. 1998;141:539–551. doi: 10.1083/jcb.141.2.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Shao Y, et al. Uniaxial cell stretching device for live-cell imaging of mechanosensitive cellular functions. Rev. Sci. Instrum. 2013;84:114304. doi: 10.1063/1.4832977. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lee J, Mei L, Chavarria D, Baker AB. In: Biomimetic Microengineering. Kim HJ, editor. Boca Raton: CRC Press; 2020. pp. 3–36. [Google Scholar]
- 36.Colombo A, Cahill PA, Lally C. An analysis of the strain field in biaxial Flexcell membranes for different waveforms and frequencies. Proc. Inst. Mech. Eng. H. 2008;222:1235–1245. doi: 10.1243/09544119JEIM428. [DOI] [PubMed] [Google Scholar]
- 37.Simmons CS, et al. Integrated strain array for cellular mechanobiology studies. J. Micromech. Microeng. 2011;21:54016–54025. doi: 10.1088/0960-1317/21/5/054016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Kamotani Y, et al. Individually programmable cell stretching microwell arrays actuated by a Braille display. Biomaterials. 2008;29:2646–2655. doi: 10.1016/j.biomaterials.2008.02.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Lee J, Wong M, Smith Q, Baker AB. A novel system for studying mechanical strain waveform-dependent responses in vascular smooth muscle cells. Lab Chip. 2013;13:4573–4582. doi: 10.1039/c3lc50894c. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Lee J, Baker AB. Computational analysis of fluid flow within a device for applying biaxial strain to cultured cells. J. Biomech. Eng. 2015;137:051006. doi: 10.1115/1.4029638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Shi G, Jin Y. Role of Oct4 in maintaining and regaining stem cell pluripotency. Stem Cell Res. Ther. 2010;1:39. doi: 10.1186/scrt39. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.An Z, et al. Sox2 and Klf4 as the functional core in pluripotency induction without exogenous Oct4. Cell Rep. 2019;29:1986–2000. doi: 10.1016/j.celrep.2019.10.026. [DOI] [PubMed] [Google Scholar]
- 43.Zhang S, Cui W. Sox2, a key factor in the regulation of pluripotency and neural differentiation. World J. Stem Cells. 2014;6:305–311. doi: 10.4252/wjsc.v6.i3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Brambrink T, et al. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell. 2008;2:151–159. doi: 10.1016/j.stem.2008.01.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Silva J, et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138:722–737. doi: 10.1016/j.cell.2009.07.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.